Passionate about IP! Since June 2003 the IPKat has covered copyright, patent, trade mark, designs, info-tech and confidentiality issues from a mainly UK and European perspective. Read, post comments and participate!

The team is Eleonora Rosati, Annsley Merelle Ward and Merpel. E-mail the Kats here!

The team is joined by GuestKats Söğüt Atilla, Oliver Fairhurst, Claire Gregg, Georgia Jenkins and Marcel Pemsel.

SpecialKats: Verónica Rodríguez Arguijo (TechieKat), Rose Hughes (PatKat) and Jocelyn Bosse (Book Review Editor).

InternKats: Wissam Bentazar, Simone Lorenzi and Kliment Markov.
Results for clinical trial
Commercial success is a nothing-burger for the EPO in Wegovy patent inventive step analysis (T 1701/22, Obesity treatment with semaglutide) Commercial success is a nothing-burger for the EPO in Wegovy patent inventive step analysis (T 1701/22, Obesity treatment with semaglutide) Reviewed by Dr Rose Hughes on Thursday, May 08, 2025 Rating: 5
"BOSWELAN" - No Special Treatment for Medicinal Product Trade Marks "BOSWELAN" - No Special Treatment for Medicinal Product Trade Marks Reviewed by Peter Ling on Tuesday, July 30, 2019 Rating: 5
Sunday Surprises Sunday Surprises Reviewed by Verónica Rodríguez Arguijo on Sunday, August 06, 2017 Rating: 5
The heart of the matter: one patent, two views The heart of the matter: one patent, two views Reviewed by Jeremy on Tuesday, July 29, 2014 Rating: 5
Subscribe to: Posts ( Atom )
Powered by Blogger.